Stanford Health Care delivers the highest levels of care and compassion. SHC treats cancer, heart disease, brain disorders, primary care issues, and many more.

Low baseline ctDNA levels in advanced breast cancer patients predict better response to targeted therapy and longer progression-free survival. The plasmaMATCH trial demonstrated that low ctDNA levels ...

In a recent study published in the Cancers Journal, researchers examined the predictors of fear of cancer recurrence (FCR) and its trajectory among breast cancer (BC) patients. Study: Protective ...

Hormone therapy initiation depends on disease extent; some agents avoid testosterone flare, allowing ADT without Casodex in certain cases. Active surveillance is increasingly chosen for favorable ...

In addition to lowering your cholesterol, keeping your brain healthy and improving mental health, new research from the University of Georgia suggests omega-3 and omega-6 fatty acids may help ward off ...

Breast cancer is one of the most prevalent cancers among women worldwide, and researchers have long sought to understand the myriad factors that may influence its development. Among these factors, ...

Elevated levels of lactate may lead to the development of cachexia (disease-related weight loss) following the onset of cancer, according to a study including data from mice and humans published in ...

The cancer death rate has been dropping across the U.S. and Western Europe during the past 30 years. Improved screening and treatments are the main reasons for the decline. However, cancer is still ...